American CryoStem (CRYO) Stock Risen 50%. Does It Hold A Huge Advantage?
ST Staff
May 19, 2021
The clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and therapies American CryoStem Corporation (OTCPink: CRYO) rose 50.86% to $0.4980 during